Verizon: The Lone 'Dog of the Dow' Dividend Champion
Finance

Verizon: The Lone 'Dog of the Dow' Dividend Champion

authorBy Lisa Jing
DateMay 02, 2026
Read time2 min

In the current market landscape, Verizon (VZ) emerges as a distinctive investment within the Dow Industrials, fulfilling the criteria for a "dogcatcher ideal" stock. This is largely due to its annual dividends, which, for every thousand dollars invested, surpass the cost of a single share. Crucially, these dividends are well-supported by the company's strong free cash flow, indicating a healthy financial position.

Looking ahead, analyst projections for top Dow dividend stocks suggest significant potential returns, with estimated net gains ranging from 19.08% to 49.46% by May 2027, based on a $10,000 investment. The average anticipated net gain stands at 29.2%. However, despite these promising forecasts, the majority of the leading Dow dividend stocks are currently overvalued, meaning their market prices are disproportionately high relative to their dividend payouts. Verizon, in contrast, is an exception, being considered fairly priced. The investment attractiveness of other companies in this group might improve if their stock prices decline or if they increase their dividends.

The financial health of a stock's dividends is often best gauged by comparing its free cash flow yield to its dividend yield. A higher free cash flow yield indicates a greater capacity to cover dividend payments. In this regard, 19 out of the 30 Dow stocks demonstrate this healthy characteristic. Yet, only Verizon not only meets this criterion, suggesting a safer dividend, but is also deemed fairly priced, making it a unique and compelling option for investors focused on dividends.

Investing in companies with strong dividend coverage and reasonable valuations, like Verizon, can provide both income and potential capital appreciation. This approach emphasizes financial prudence and a long-term perspective, aligning with a strategy focused on sustainable growth and responsible investment. Seeking opportunities in companies that are fundamentally sound and offer fair value can lead to positive outcomes for investors.

More Articles
Finance
Wingstop: Franchise Expansion At Risk As Sales Slow (Rating Downgrade)
Wingstop has been downgraded to Sell due to declining same-store sales and overly ambitious expansion targets. The company now anticipates a low single-digit decline in same-store sales for FY26, a significant shift from previous growth expectations. Franchisee margin pressures, weak comparable sales, and broader economic challenges make the projected 16% location growth highly unrealistic. Despite a recent market correction, WING's valuation at 20x forward EBITDA offers poor value compared to competitors with stronger fundamentals.
By David RubensteinMay 02, 2026
Finance
Alphabet's Strong Q1 Performance Driven by Google Cloud and AI Strategy
Alphabet (GOOG) delivered an impressive Q1 CY26 result, with Google Cloud revenue surging 63% year-over-year to $20 billion and its backlog nearly doubling to $460 billion. The company's multi-dimensional enterprise AI strategy, encompassing chips, models, and applications, is driving rapid market share gains against competitors like OpenAI. Paid subscriptions for Google's Gemini Enterprise grew by 40% quarter-over-quarter, outpacing estimated sequential growth rates for OpenAI's paid subscriptions. Management's minimal 3% capital expenditure increase for CY26 signals strong capital efficiency, with return on invested capital (ROIC) expanding from 32% to 35.2% and earnings per share (EPS) growth now projected at 24%.
By Michele FerreroMay 02, 2026
Finance
Merck's Strategic Evolution: R&D and M&A Fuel Future Growth Despite Patent Challenges
Merck's updated FY2026 adjusted EPS guidance, impacted by IPR&D charges from recent acquisitions, reflects a strategic shift. Despite these optics, the company's strong in-house capabilities, successful transition to KEYTRUDA QLEX, and the FDA approval of Idvynso (offering double-digit billion revenue potential) underscore its robust pipeline. Aggressive M&A activities are set to bolster Merck's mid-2030s revenue target of over $70 billion, mitigating risks from KEYTRUDA's upcoming patent expiration. This ongoing portfolio rejuvenation, supported by a healthy balance sheet, well-managed interest expenses, and ample cash flows, positions Merck for an estimated 73% 5-year total return, targeting a fair value of $156 with a 3.11% forward dividend yield.
By Morgan HouselMay 02, 2026
Finance
Newmont Corporation: Gold Prices, Oil Costs, And Strong Profits
Newmont Corporation (NEM) shares are trading 20% below their January peak, despite reporting record Q1 earnings and robust free cash flow. The company posted Q1 non-GAAP EPS of $2.90 and $7.3 billion in revenue, exceeding analyst estimates. A substantial $3.1 billion in free cash flow and a new $6 billion share repurchase program further highlight its financial strength. The stock's valuation appears appealing, with an intrinsic value of $147 based on normalized EPS of $10.50 and a 14x P/E ratio, though potential risks from fluctuating gold prices and rising oil costs bear watching.
By David RubensteinMay 02, 2026
Finance
Unlocking High Yields in Mortgage REITs: A Pathway to Personal Income
Mortgage Real Estate Investment Trusts (mREITs) are demonstrating a significant turnaround, driven by a stabilizing yield curve which is revitalizing their cash flow. Annaly (NLY) is showcasing strong dividend coverage with potential for future increases, while Dynex (DX) strategically expanded its portfolio to capitalize on high mortgage yields. These investments offer a robust defense against economic fluctuations, providing a secure income stream even when broader markets face downturns.
By Nouriel RoubiniMay 02, 2026